Ipsen, a France-based biopharmaceutical company, has named Ian Weatherhead as its new vice president, corporate external communications, it was reported yesterday.
Weatherhead has 20 years of corporate communications experience within the life sciences sector, most recently at Teva UK/Ireland where he led its corporate communications and government affairs team. Prior to that he held global, regional and affiliate roles with AstraZeneca, Syngenta, UCB and Sanofi.
In his new role at Ipsen, Weatherhead will be responsible for the design and implementation of an external corporate communications strategy. Weatherhead will report to senior vice president, public affairs and corporate communications, Didier Veron.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer